Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent
- PMID: 15232722
- DOI: 10.1007/s00775-004-0560-1
Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent
Abstract
We report the development of functionalized superparamagnetic iron oxide nanoparticles with a PEG-modified, phospholipid micelle coating, and their delivery into living cells. The size of the coated particles, as determined by dynamic light scattering and electron microscopy, was found to be between 12 and 14 nm. The PEG-phospholipid coating resulted in high water solubility and stability, and the functional groups of modified PEG allowed for bioconjugation of various moieties, including a fluorescent dye and the Tat peptide. Efficient delivery of the functionalized nanoparticles into living cells was confirmed by fluorescence microscopy, relaxation time measurements, and magnetic resonance imaging (MRI). This demonstrates the feasibility of using functionalized magnetic nanoparticles with uniform (approximately 10 nm) sizes as an MRI contrast agent for intracellular molecular imaging in deep tissue. These micelle-coated iron oxide nanoparticles offer a versatile platform for conjugation of a variety of moieties, and their small size confers advantages for intracellular molecular imaging with minimal perturbation.
Similar articles
-
Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.J Biomater Sci Polym Ed. 2012;23(15):1903-22. doi: 10.1163/092050611X598329. Epub 2012 May 8. J Biomater Sci Polym Ed. 2012. PMID: 22024467
-
Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.Drug Dev Ind Pharm. 2010 Oct;36(10):1235-44. doi: 10.3109/03639041003710151. Drug Dev Ind Pharm. 2010. PMID: 20818962
-
Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies.IEEE Trans Nanobioscience. 2004 Mar;3(1):66-73. doi: 10.1109/tnb.2003.820277. IEEE Trans Nanobioscience. 2004. PMID: 15382647
-
Magnetic iron oxide nanoparticles for biomedical applications.Future Med Chem. 2010 Mar;2(3):427-49. doi: 10.4155/fmc.09.164. Future Med Chem. 2010. PMID: 21426176 Review.
-
Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents.Chem Soc Rev. 2012 Apr 7;41(7):2575-89. doi: 10.1039/c1cs15248c. Epub 2011 Dec 2. Chem Soc Rev. 2012. PMID: 22138852 Review.
Cited by
-
A calibration curve for immobilized dihydrofolate reductase activity assay.Data Brief. 2015 Apr 20;4:19-21. doi: 10.1016/j.dib.2015.04.005. eCollection 2015 Sep. Data Brief. 2015. PMID: 26217755 Free PMC article.
-
Preparation of Self-Assembled Nanoparticle-Polymer Hybrids from Modified Silica Nanoparticles and Polystyrene-Block-Polyacrylic Acid Vesicles via the Co-Precipitation Method.Polymers (Basel). 2023 Jan 14;15(2):444. doi: 10.3390/polym15020444. Polymers (Basel). 2023. PMID: 36679323 Free PMC article.
-
Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer.Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):301-10. doi: 10.1007/s00259-005-1908-7. Epub 2005 Oct 29. Eur J Nucl Med Mol Imaging. 2006. PMID: 16258763
-
Multimodal MRI contrast agents.J Biol Inorg Chem. 2007 Sep;12(7):939-49. doi: 10.1007/s00775-007-0265-3. Epub 2007 Jul 21. J Biol Inorg Chem. 2007. PMID: 17659368 Review. No abstract available.
-
Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application.J Nanobiotechnology. 2012 Jun 25;10:27. doi: 10.1186/1477-3155-10-27. J Nanobiotechnology. 2012. PMID: 22731703 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical